Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Janet M Allen

Showing results (31-40 of 85) with videos related to

Pageof 9
Sort By:
Diabetes Care|January 11, 2011
Closed-loop insulin delivery during pregnancy complicated by type 1 diabetesHelen R Murphy, Daniela Elleri, Janet M Allen, et al.
Diabetes Technology & Therapeutics|November 5, 2013
Accuracy of subcutaneous continuous glucose monitoring in critically ill adults: improved sensor performance with enhanced calibrationsLalantha Leelarathna, Shane W English, Hood Thabit, et al.
Critical Care (London, England)|July 26, 2013
Feasibility of fully automated closed-loop glucose control using continuous subcutaneous glucose measurements in critical illness: a randomized controlled trialLalantha Leelarathna, Shane W English, Hood Thabit, et al.
Journal of Diabetes Science and Technology|April 13, 2024
Hypoglycemia and Hyperglycemia According to Type of Diabetes: Observations During Fully Closed-Loop Insulin Delivery in Adults With Type 1 and Type 2 DiabetesNithya Kadiyala, Malgorzata E Wilinska, Aideen B Daly, et al.
Diabetes Care|October 21, 2011
Safety and efficacy of 24-h closed-loop insulin delivery in well-controlled pregnant women with type 1 diabetes: a randomized crossover case seriesHelen R Murphy, Kavita Kumareswaran, Daniela Elleri, et al.
Diabetes Care|February 14, 2013
Physical activity energy expenditure and glucose control in pregnant women with type 1 diabetes: is 30 minutes of daily exercise enough?Kavita Kumareswaran, Daniela Elleri, Janet M Allen, et al.
The Lancet. Diabetes & Endocrinology|January 18, 2017
Day-and-night glycaemic control with closed-loop insulin delivery versus conventional insulin pump therapy in free-living adults with well controlled type 1 diabetes: an open-label, randomised, crossover studyLia Bally, Hood Thabit, Harald Kojzar, et al.
Diabetes Technology & Therapeutics|February 13, 2020
What Training, Support, and Resourcing Do Health Professionals Need to Support People Using a Closed-Loop System? A Qualitative Interview Study with Health Professionals Involved in the Closed Loop from Onset in Type 1 Diabetes (CLOuD) TrialBarbara Kimbell, David Rankin, Nicole L Ashcroft, et al.
Diabetes Technology & Therapeutics|February 19, 2021
Data Sharing While Using a Closed-Loop System: Qualitative Study of Adolescents' and Parents' Experiences and ViewsJulia Lawton, Ruth I Hart, Barbara Kimbell, et al.
Diabetes Technology & Therapeutics|December 22, 2012
Evaluating the accuracy and large inaccuracy of two continuous glucose monitoring systemsLalantha Leelarathna, Marianna Nodale, Janet M Allen, et al.
Pageof 9

Showing results (31-40 of 85) with videos related to

Sort By:
Pageof 9
Diabetes Care|January 11, 2011
Closed-loop insulin delivery during pregnancy complicated by type 1 diabetesHelen R Murphy, Daniela Elleri, Janet M Allen, et al.
Diabetes Technology & Therapeutics|November 5, 2013
Accuracy of subcutaneous continuous glucose monitoring in critically ill adults: improved sensor performance with enhanced calibrationsLalantha Leelarathna, Shane W English, Hood Thabit, et al.
Critical Care (London, England)|July 26, 2013
Feasibility of fully automated closed-loop glucose control using continuous subcutaneous glucose measurements in critical illness: a randomized controlled trialLalantha Leelarathna, Shane W English, Hood Thabit, et al.
Journal of Diabetes Science and Technology|April 13, 2024
Hypoglycemia and Hyperglycemia According to Type of Diabetes: Observations During Fully Closed-Loop Insulin Delivery in Adults With Type 1 and Type 2 DiabetesNithya Kadiyala, Malgorzata E Wilinska, Aideen B Daly, et al.
Diabetes Care|October 21, 2011
Safety and efficacy of 24-h closed-loop insulin delivery in well-controlled pregnant women with type 1 diabetes: a randomized crossover case seriesHelen R Murphy, Kavita Kumareswaran, Daniela Elleri, et al.
Diabetes Care|February 14, 2013
Physical activity energy expenditure and glucose control in pregnant women with type 1 diabetes: is 30 minutes of daily exercise enough?Kavita Kumareswaran, Daniela Elleri, Janet M Allen, et al.
The Lancet. Diabetes & Endocrinology|January 18, 2017
Day-and-night glycaemic control with closed-loop insulin delivery versus conventional insulin pump therapy in free-living adults with well controlled type 1 diabetes: an open-label, randomised, crossover studyLia Bally, Hood Thabit, Harald Kojzar, et al.
Diabetes Technology & Therapeutics|February 13, 2020
What Training, Support, and Resourcing Do Health Professionals Need to Support People Using a Closed-Loop System? A Qualitative Interview Study with Health Professionals Involved in the Closed Loop from Onset in Type 1 Diabetes (CLOuD) TrialBarbara Kimbell, David Rankin, Nicole L Ashcroft, et al.
Diabetes Technology & Therapeutics|February 19, 2021
Data Sharing While Using a Closed-Loop System: Qualitative Study of Adolescents' and Parents' Experiences and ViewsJulia Lawton, Ruth I Hart, Barbara Kimbell, et al.
Diabetes Technology & Therapeutics|December 22, 2012
Evaluating the accuracy and large inaccuracy of two continuous glucose monitoring systemsLalantha Leelarathna, Marianna Nodale, Janet M Allen, et al.
Pageof 9